How to taper off a GLP-1 safely
Tapering means stepping the dose down over months rather than stopping outright, so appetite returns gradually instead of all at once. The dose decisions belong to your prescriber. Your job is the other half: having a stable meal structure, protein intake, training routine and relapse plan in place before the first reduction.
Last updated: 30 August 2026
Why taper at all — why not just stop?
Because an abrupt stop compresses the whole transition into two or three weeks.
Your gut makes its own GLP-1, in short bursts after meals, and it is cleared from the blood within minutes. The medication provides something far larger and far steadier. Stop suddenly and that whole signal disappears over a few weeks, leaving only your own — which was never the same size. That drop is what people experience as hunger returning all at once.
Tapering doesn’t remove the drop. It stretches it out, so each step down is a change you can adapt to rather than a cliff you fall off — and it gives the things that do influence your own signal, food and movement, time to take on more of the work.
There is a second, less physiological reason: a gradual reduction gives you time to find out which habits actually hold. A habit that survives a 20% dose reduction is a habit. A habit that has only ever been tested while fully medicated is a hypothesis.
What does a taper usually look like?
There is no universal protocol, and clinicians describe this as a judgement call rather than a standard. The pattern most commonly discussed in 2026 works in steps:
1. One step down at a time — often around a 20% reduction, or the same increments used when the dose was escalated. Some prescribers instead extend the interval between injections (for example every ten days rather than every seven).
2. Hold and observe for four to twelve weeks at each new dose before the next reduction.
3. Track three things daily or weekly: hunger and food noise on a 0–10 scale, weight, and waist measurement.
4. Only step down again if the previous step held. If hunger stays manageable and there are no uncontrolled eating episodes, continue. If the rebound is noticeable but manageable, stay at that dose longer. If it is severe, that is a conversation with your prescriber, not something to push through.
Realistically this takes months, not weeks. There is no external deadline — a rushed taper is worse than a slow one.
All of the above is a description of what prescribers discuss, not an instruction. Never change a prescribed dose on your own.
Are you ready to start?
A readiness checklist
This is the part nobody screens for, and it is the part that decides how the taper goes. Six criteria — ideally all six in place before the first reduction:
☐ 1. Meal structure is stable. Three fixed mealtimes, held for at least three weeks, without regular late-night snacking.
☐ 2. Protein target is being met. At least 1.4 g per kg of body weight on five days out of seven, with a breakfast of 25 g or more as routine rather than exception.
☐ 3. Movement routine is established. Resistance training at least twice a week plus daily walking, held for at least two weeks without needing external reminders.
☐ 4. Body composition is in your own steady range. Not an ideal weight — a stable or improving waist measurement and no uncontrolled gain in the last three weeks.
☐ 5. Coping strategies are known and practised. Your top three triggers identified, a working strategy for each, each used successfully at least three times.
☐ 6. A written relapse plan exists. What you will do if hunger returns, who you will contact, and which early warning signs you personally recognise.
Six out of six: you are in a good position to start, with your prescriber. Four or five: possible, but with closer support. Fewer than four: not yet. Close the open points first — there is no time pressure, and a poorly prepared taper is worse than a delayed one.
What should you say to your prescriber?
Come with specifics rather than a general question. A useful structure:
• What you want: “I’d like to plan a gradual reduction rather than stopping outright.”
• What you have in place: your meal structure, protein intake, training, and how long each has held.
• What you want to agree: the size of the first step, how long you hold it, what you will monitor, and at what point you would contact them.
• What you want to know: whether any of your other medications — for diabetes, blood pressure or cholesterol — need reviewing as your weight changes.
Ask about a low maintenance dose as an explicit option. It is not the failure route.
What if the taper doesn’t work?
Some people cannot come off entirely, and there are legitimate medical reasons for that. Staying on a low maintenance dose is a recognised path, discussed openly in 2026 rather than treated as defeat. The nutritional and behavioural work is not wasted in that case — it is what makes the lower dose sustainable.
The framing that causes harm is all-or-nothing. The habits stay; the medication can change; both have value.
Does anything help bridge the gap?
Two honest answers.
Food does most of the work. Protein at every meal, soluble fibre, and a longer overnight gap all support your own GLP-1 and satiety signalling. This is unglamorous and it is the main event — see Can your body make its own GLP-1?
Some botanical options have short-term data. Bitter compounds delivered to the small intestine — a hops extract is the best studied — raise GLP-1, CCK and PYY several-fold above baseline for a few hours and reduce hunger and food cravings in short trials. Two caveats worth having: those trials are small and mostly in healthy-weight volunteers, and the longer weight-loss trial reported for this ingredient was funded by its manufacturer, which is a reason for caution rather than dismissal. Useful as a bridge for one difficult time of day; not a substitute for the structure. If you take regular medication, tell your doctor before adding anything.
Be sceptical of anything marketed as “nature’s Ozempic”. Almost any meal containing fibre raises GLP-1 above fasting level — “boosts GLP-1” on a label tells you very little on its own.
What does the UK guidance say?
NICE quality standard QS212 (2025) states that people stopping weight-management medication should receive advice and support to maintain the changes they have made — well-rehearsed “if–then” action plans they can put into practice, monitoring at regular intervals for a minimum of one year, help building routines that support the new behaviour, and the social support needed to maintain it. If you are paying privately, ask what your provider offers against that standard before your last prescription, not after.
Sources
• NICE. Overweight and obesity management, Quality Standard QS212, statement 7 (2025). Link
• Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. PubMed
• Medical University of South Carolina. Life after Ozempic: what happens when you stop a GLP-1? (2026). Link
This page is general information about nutrition and lifestyle. It is not medical advice and does not describe a dosing regimen for you to follow. Decisions about your medication and its dose are for you and your prescriber.
PS NOW is an independent eight-week programme for women coming off GLP-1 medication — no prescriptions, no medication sales, no commission.
See how it works.